ACLX
Price
$85.07
Change
+$2.83 (+3.44%)
Updated
Oct 3 closing price
Capitalization
4.72B
42 days until earnings call
XFOR
Price
$3.48
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
78.12M
Interact to see
Advertisement

ACLX vs XFOR

Header iconACLX vs XFOR Comparison
Open Charts ACLX vs XFORBanner chart's image
Arcellx
Price$85.07
Change+$2.83 (+3.44%)
Volume$924.55K
Capitalization4.72B
X4 Pharmaceuticals
Price$3.48
Change-$0.00 (-0.00%)
Volume$212.11K
Capitalization78.12M
ACLX vs XFOR Comparison Chart in %
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. XFOR commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and XFOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ACLX: $85.07 vs. XFOR: $3.48)
Brand notoriety: ACLX and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 176% vs. XFOR: 4%
Market capitalization -- ACLX: $4.72B vs. XFOR: $78.12M
ACLX [@Biotechnology] is valued at $4.72B. XFOR’s [@Biotechnology] market capitalization is $78.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and XFOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while XFOR’s TA Score has 2 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 4 bearish.
  • XFOR’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than XFOR.

Price Growth

ACLX (@Biotechnology) experienced а +6.67% price change this week, while XFOR (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.72B) has a higher market cap than XFOR($78.1M). ACLX YTD gains are higher at: 10.927 vs. XFOR (-84.188). XFOR has higher annual earnings (EBITDA): -91.11M vs. ACLX (-179.78M). ACLX has more cash in the bank: 453M vs. XFOR (63M). ACLX has less debt than XFOR: ACLX (52.5M) vs XFOR (78M). ACLX has higher revenues than XFOR: ACLX (57M) vs XFOR (32.8M).
ACLXXFORACLX / XFOR
Capitalization4.72B78.1M6,041%
EBITDA-179.78M-91.11M197%
Gain YTD10.927-84.188-13%
P/E RatioN/A0.71-
Revenue57M32.8M174%
Total Cash453M63M719%
Total Debt52.5M78M67%
FUNDAMENTALS RATINGS
XFOR: Fundamental Ratings
XFOR
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXXFOR
RSI
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLXNF18.100.95
+5.54%
PLUXEE N V
GBBYF0.17N/A
N/A
Goodbaby International Holdings Ltd
POFCF0.06N/A
N/A
Petrofac Ltd
TKGSF38.19N/A
N/A
Tokyo Gas Co., Ltd.
CRBO0.20N/A
N/A
Carbon Energy Corporation